中国小儿急救医学
中國小兒急救醫學
중국소인급구의학
CHINESE PEDIATRIC EMERGENCY MEDICINE
2012年
4期
380-382
,共3页
代东伶%王国兵%陈森敏%刘晓红%周少明
代東伶%王國兵%陳森敏%劉曉紅%週少明
대동령%왕국병%진삼민%류효홍%주소명
胃肠功能紊乱%红霉素%婴儿,新生
胃腸功能紊亂%紅黴素%嬰兒,新生
위장공능문란%홍매소%영인,신생
Functional gastrointestinal dysmotility%Erythromycin%Infant,newborn
目的 评估口服红霉素对新生儿胃肠道功能紊乱的疗效.方法 采用随机、双盲、安慰剂对照试验,选择2009年1月至2011年12月于深圳市儿童医院新生儿重症监护室住院的90例患儿作为研究对象,随机分为小剂量红霉素组、大剂量红霉素组和对照组,每组30例,分别给予3 mg/(kg·次)、10 mg/(kg·次)红霉素或等量生理盐水口服或鼻饲,每8小时1次,疗程14 d.比较各组患儿达到半量、3/4量及全量肠内营养时间、肠外营养时间及住院时间.结果 与对照组[(8.1±0.4)d,(13.5±1.0)d,(15.7±1.2)d]比较,大剂量红霉素组[(3.0±0.5)d,(6.2±0.7)d,(8.2±1.0)d]和小剂量红霉素组[(6.2±0.5)d,(8.3±0.6)d,(10.6±1.1)d]患儿达到半量、3/4量及全量肠内营养的时间均明显提前(P<0.05).肠外营养时间[(14.2±1.4)d vs (9.3±1.2)d vs (7.8±1.1)d]及住院时间[(13.0±1.4)d vs (8.1 ±0.8)d vs (6.8±0.7)d],对照组明显长于不同剂量红霉素组,3组间比较差异均有统计学意义(P<0.05).治疗期间发生肝功能损害、脓毒症的患儿,不同剂最红霉素组两组相似,但是比对照组明显降低.未见口服红霉素治疗的相关不良反应(QT间期延长、心律失常).结论 口服红霉素可以作为肠内营养不足的新生儿胃肠道功能紊乱的治疗方法,并且口服大剂量红霉素较小剂量效果更好.
目的 評估口服紅黴素對新生兒胃腸道功能紊亂的療效.方法 採用隨機、雙盲、安慰劑對照試驗,選擇2009年1月至2011年12月于深圳市兒童醫院新生兒重癥鑑護室住院的90例患兒作為研究對象,隨機分為小劑量紅黴素組、大劑量紅黴素組和對照組,每組30例,分彆給予3 mg/(kg·次)、10 mg/(kg·次)紅黴素或等量生理鹽水口服或鼻飼,每8小時1次,療程14 d.比較各組患兒達到半量、3/4量及全量腸內營養時間、腸外營養時間及住院時間.結果 與對照組[(8.1±0.4)d,(13.5±1.0)d,(15.7±1.2)d]比較,大劑量紅黴素組[(3.0±0.5)d,(6.2±0.7)d,(8.2±1.0)d]和小劑量紅黴素組[(6.2±0.5)d,(8.3±0.6)d,(10.6±1.1)d]患兒達到半量、3/4量及全量腸內營養的時間均明顯提前(P<0.05).腸外營養時間[(14.2±1.4)d vs (9.3±1.2)d vs (7.8±1.1)d]及住院時間[(13.0±1.4)d vs (8.1 ±0.8)d vs (6.8±0.7)d],對照組明顯長于不同劑量紅黴素組,3組間比較差異均有統計學意義(P<0.05).治療期間髮生肝功能損害、膿毒癥的患兒,不同劑最紅黴素組兩組相似,但是比對照組明顯降低.未見口服紅黴素治療的相關不良反應(QT間期延長、心律失常).結論 口服紅黴素可以作為腸內營養不足的新生兒胃腸道功能紊亂的治療方法,併且口服大劑量紅黴素較小劑量效果更好.
목적 평고구복홍매소대신생인위장도공능문란적료효.방법 채용수궤、쌍맹、안위제대조시험,선택2009년1월지2011년12월우심수시인동의원신생인중증감호실주원적90례환인작위연구대상,수궤분위소제량홍매소조、대제량홍매소조화대조조,매조30례,분별급여3 mg/(kg·차)、10 mg/(kg·차)홍매소혹등량생리염수구복혹비사,매8소시1차,료정14 d.비교각조환인체도반량、3/4량급전량장내영양시간、장외영양시간급주원시간.결과 여대조조[(8.1±0.4)d,(13.5±1.0)d,(15.7±1.2)d]비교,대제량홍매소조[(3.0±0.5)d,(6.2±0.7)d,(8.2±1.0)d]화소제량홍매소조[(6.2±0.5)d,(8.3±0.6)d,(10.6±1.1)d]환인체도반량、3/4량급전량장내영양적시간균명현제전(P<0.05).장외영양시간[(14.2±1.4)d vs (9.3±1.2)d vs (7.8±1.1)d]급주원시간[(13.0±1.4)d vs (8.1 ±0.8)d vs (6.8±0.7)d],대조조명현장우불동제량홍매소조,3조간비교차이균유통계학의의(P<0.05).치료기간발생간공능손해、농독증적환인,불동제최홍매소조량조상사,단시비대조조명현강저.미견구복홍매소치료적상관불량반응(QT간기연장、심률실상).결론 구복홍매소가이작위장내영양불족적신생인위장도공능문란적치료방법,병차구복대제량홍매소교소제량효과경호.
Objective To assess the efficacy of oral erythromycin on the functional gastrointestinal dysmotility in neonates.Methods In this double-blind,randomized,placebo controlled trial,90 neonates consecutively admitted to the neonatal intensive care unit of Shenzhen Children's Hospital from Jan 2009 to Dec 2011 were enrolled and randomly divided into low-dosage erythromycin group ( LE group,n =30 ),highdosage erythromycin group ( HE group,n =30 ) and control group ( n =30).Patients received either erythromycin ( 3 mg/kg or 10 mg/kg) or equivalent normal saline with oral or nasal feeding every 8 hours one time for 14 d.The time to achieve half,three-quarters,and full enteral nutrition,the time of parenteral nutrition,and hospital length of stay were compared among each group.Results The time to achieve half,three-quarters,and full enteral nutrition in HE group [ ( 3.0 ± 0.5 ) d,( 6.2 ± 0.7 ) d,( 8.2 ± 1.0 ) d ] and in LE group [(6.2±0.5) d,(8.3 ±0.6) d,(10.6 ±1.1) d] were shorter than that in control group [(8.1 ±0.4) d,( 13.5 ± 1.0) d,( 15.7 ± 1.2) d] ( P < 0.05 ).The duration of parenteral nutrition [ ( 14.2 ± 1.4) d vs (9.3 ± 1.2) d vs (7.8 ± 1.1 ) d ] and hospital length of stay [ ( 13.0 ± 1.4 ) d vs ( 8.1 ± 0.8 ) d vs ( 6.8 ±0.7) d] were significantly prolonged in control group compared with LE and HE groups,and there were significant differences among the three groups ( P < 0.05).The incidence of liver injury and septicemia during the treatment of erythromycin were similar between HE group and LE group,but it was significantly lower than control group.No serious adverse effect such as prolongation of QT intervals,dysrhythmia associated with erythromycin treatment was found.Conclusion Oral erythromycin can be considered as a treatment for neonates with functional gastrointestinal dysmotility who fail to establish adequate enteral nutrition,and highdosage oral erythromycin is more effective than low-dosage.